SDIX to Report Third Quarter 2012 Results on November 12, 2012

  SDIX to Report Third Quarter 2012 Results on November 12, 2012

Business Wire

NEWARK, Del. -- November 05, 2012

SDIX (Nasdaq: SDIX) - a leading provider of biotechnology-based products and
services for a broad range of life science, biotechnology and diagnostic
applications - expects to release its third quarter 2012 results at
approximately 4 p.m. ET on Monday, November 12, 2012. The Company has
scheduled an investor conference call for 4:30 p.m. ET on the same day.

The dial-in number for the live conference call will be 877-407-8035
(201-689-8035 outside the U.S.). A live webcast of the conference call will be
available on the Company’s website, www.sdix.com, as well as
www.investorcalendar.com. For those who cannot listen to the live broadcast,
an audio replay of the call will be available on each of these websites for 90
days. Telephone replays of the call will be available from 7:30 p.m. ET on
November 12, 2012 through 11:59 p.m. ET on November 26, 2012. To listen to the
telephone replay, dial 877-660-6853 (201-612-7415 outside the U.S.) and enter
account number 286 and conference ID 403556.

About SDIX (www.sdix.com)

SDIX is a biotechnology company with a core expertise in creating better
antigens, better antibodies and better assays for the pharmaceutical and
biotechnology markets. For over 20 years, SDIX has been a leading
immuno-solutions company, developing results-oriented and innovative
antibody-based solutions that enable customers to meet high performance
research, diagnostic and commercialization objectives.

SDIX’s technology and capabilities are being used to help discover disease
mechanisms, facilitate development of new drugs and provide antibodies and
assays for the diagnosis of disease.

This news release may contain forward-looking statements reflecting SDIX's
current expectations. When used in this press release, words like
“anticipate”, “could”, “enable”, “estimate”, “intend”, “expect”, “believe”,
“potential”, “will”, “should”, “project”, “plan” and similar expressions as
they relate to SDIX are intended to identify said forward-looking statements.
Investors are cautioned that all forward-looking statements involve risks and
uncertainties, which may cause actual results to differ from those anticipated
by SDIX at this time. Such risks and uncertainties include, without
limitation, changes in demand for products, the application of our
technologies to various uses, delays in product development, delays in market
acceptance of new products, retention of customers and employees, adequate
supply of raw materials, inability to obtain or delays in obtaining fourth
party or required government approvals, the ability to meet increased market
demand, competition, protection of intellectual property, non-infringement of
intellectual property, seasonality, and other factors more fully described in
SDIX's public filings with the U.S. Securities and Exchange Commission.

Contact:

SDIX
Kevin Bratton
Chief Financial Officer
302-456-6789
kbratton@sdix.com
 
Press spacebar to pause and continue. Press esc to stop.